Jan 13, 2022 · Salarius is a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new treatment options

Salarius Pharmaceuticals is a cancer-focused biopharmaceutical company using targeted protein inhibition and targeted protein degradation to develop new therapies to address gene …

Find the latest Salarius Pharmaceuticals, Inc. (SLRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Apr 1, 2025 · Salarius Pharmaceuticals Shares Are Skyrocketing Today: What's Going On? SLRX | Complete Salarius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock …

Jan 13, 2025 · HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company …

Mar 26, 2025 · Salarius Pharmaceuticals, Inc. These candidates, previously shown to be active in vitro against respiratory syncytial virus (RSV) and human parainfluenza virus 3 (hPIV3), show …

Jan 13, 2025 · Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company with two drug candidates for patients with cancer in need of new treatment options.

Dec 31, 2024 · HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and …

Apr 4, 2025 · Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat …

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP …